Scientists Develop SynTrogo Tool to Selectively Edit Brain Circuits and Enhance Memory
Key Takeaways
- ▸SynTrogo is the first molecular tool to enable direct, targeted editing of physical brain circuit architecture independent of neuronal activity
- ▸The platform harnesses engineered interactions between neurons and astrocytes to selectively reduce synaptic connections through a synthetic trogocytosis process
- ▸Testing in the hippocampus showed that selective synaptic pruning strengthened remaining connections and enhanced neural circuit efficiency
Summary
Researchers at the Institute for Basic Science (IBS) Center for Memory and Glioscience, in collaboration with the Korea Brain Research Institute (KBRI), have developed SynTrogo (Synthetic Trogocytosis), a groundbreaking molecular tool that enables direct editing of brain circuit architecture. The platform harnesses astrocytes—star-shaped glial cells—to selectively dismantle synaptic connections through a synthetic trogocytosis-like process, working independently of neural activity. This represents the first demonstration of "connectome editing," allowing researchers to deliberately trigger synaptic pruning at chosen brain locations.
When tested in the hippocampus—a region crucial for learning and memory—SynTrogo reduced excitatory synapses by approximately 27 percent over three weeks. Surprisingly, this reduction led to enhanced function: the surviving synapses became structurally and functionally stronger, with enlarged presynaptic boutons, increased synaptic vesicle numbers, and more efficient signal transmission. The research opens new possibilities for understanding and potentially treating neurological disorders linked to dysregulated synaptic pruning, including schizophrenia, autism spectrum disorder, and Alzheimer's disease.
- This breakthrough could lead to new therapeutic approaches for neurological disorders associated with abnormal synaptic pruning
Editorial Opinion
SynTrogo represents a paradigm shift in neuroscience, moving beyond modulating neural activity to directly rewiring brain architecture itself. The counterintuitive finding that removing 27 percent of synapses actually strengthened circuit function challenges conventional assumptions about synaptic density and efficiency. While the therapeutic potential for disorders like Alzheimer's and autism is compelling, this research raises important questions about safety, reversibility, and the long-term effects of connectome editing that will need careful exploration before clinical applications.
